Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-06
DOI
10.1038/s41541-019-0147-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
- (2019) Ivan Kosik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
- (2019) David I Bernstein et al. LANCET INFECTIOUS DISEASES
- Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults
- (2018) Carine Claeys et al. BMC INFECTIOUS DISEASES
- The influenza virus hemagglutinin head evolves faster than the stalk domain
- (2018) Ericka Kirkpatrick et al. Scientific Reports
- Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial
- (2017) Anuradha Madan et al. VACCINE
- Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
- (2017) Henning Jacobsen et al. mBio
- Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
- (2017) Daniel Stadlbauer et al. mSphere
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
- (2017) Raffael Nachbagauer et al. npj Vaccines
- Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination
- (2016) Ali H Ellebedy et al. NATURE IMMUNOLOGY
- Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
- (2016) Paul E. Leon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin
- (2016) Michael Doud et al. Viruses-Basel
- Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
- (2016) Raffael Nachbagauer et al. mBio
- Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
- (2016) Caitlin E. Mullarkey et al. mBio
- A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
- (2016) Raffael Nachbagauer et al. npj Vaccines
- Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial
- (2015) Anne Schuind et al. JOURNAL OF INFECTIOUS DISEASES
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial
- (2015) Joanne M. Langley et al. VACCINE
- Influenza: Can we cope better with the unpredictable?
- (2015) Gaël Dos Santos et al. Human Vaccines & Immunotherapeutics
- AS03B-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial
- (2014) Pope Kosalaraksa et al. JOURNAL OF INFECTIOUS DISEASES
- Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
- (2014) F. Krammer et al. JOURNAL OF VIROLOGY
- Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
- (2014) R. Nachbagauer et al. JOURNAL OF VIROLOGY
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
- (2014) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Universal influenza virus vaccines: need for clinical trials
- (2013) Florian Krammer et al. NATURE IMMUNOLOGY
- Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
- (2013) Peter H. Goff et al. PLoS One
- Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
- (2013) N. S. Heaton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza virus hemagglutinin stalk-based antibodies and vaccines
- (2013) Florian Krammer et al. Current Opinion in Virology
- A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine
- (2012) Joanne M Langley et al. BMC INFECTIOUS DISEASES
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- An assessment of prime-boost vaccination schedules with AS03A-adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults
- (2012) Paul Gillard et al. Influenza and Other Respiratory Viruses
- A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
- (2012) G. S. Tan et al. JOURNAL OF VIROLOGY
- A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
- (2012) Florian Krammer et al. PLoS One
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
- (2012) N. Pica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design
- (2011) Denise A. Kaminski Frontiers in Immunology
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
- (2008) Jens Wrammert et al. NATURE
- The biology of influenza viruses
- (2008) Nicole M. Bouvier et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started